Mckesson Corp
NYSE:MCK

Watchlist Manager
Mckesson Corp Logo
Mckesson Corp
NYSE:MCK
Watchlist
Price: 611.99 USD -0.96% Market Closed
Market Cap: 77.7B USD
Have any thoughts about
Mckesson Corp?
Write Note

Gross Margin
Mckesson Corp

3.9%
Current
5%
Average
47.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
3.9%
=
Gross Profit
13B
/
Revenue
330.2B

Gross Margin Across Competitors

Country US
Market Cap 77.7B USD
Gross Margin
4%
Country US
Market Cap 48.9B USD
Gross Margin
3%
Country US
Market Cap 48.4B USD
Gross Margin
3%
Country US
Market Cap 30.3B USD
Gross Margin
3%
Country US
Market Cap 9.3B USD
Gross Margin
32%
Country CN
Market Cap 65B CNY
Gross Margin
32%
Country KR
Market Cap 12.2T KRW
Gross Margin
30%
Country CN
Market Cap 65.4B HKD
Gross Margin
8%
Country CN
Market Cap 60.9B CNY
Gross Margin
11%
Country IT
Market Cap 5.5B EUR
Gross Margin
24%
Country DE
Market Cap 5B EUR
Gross Margin
10%
No Stocks Found

Mckesson Corp
Glance View

Market Cap
77.7B USD
Industry
Health Care
Economic Moat
Narrow

McKesson Corporation stands as a cornerstone of the healthcare industry, playing a vital role in the distribution and management of pharmaceuticals and healthcare services. Founded in 1833, the company has evolved from its early days as a drug wholesaler into a formidable player providing critical support in the supply chain for hospitals, pharmacies, and healthcare providers across the United States and beyond. With a strong commitment to enhancing patient care, McKesson offers a comprehensive range of services, including the distribution of prescription medications, health information technology, and pharmacy management. This diverse portfolio not only strengthens the company’s market position but also underscores its commitment to improving healthcare outcomes. For investors, McKesson represents both a growth opportunity and a stable investment in the ever-evolving healthcare landscape. The company's robust revenue streams, driven by increasing demand for pharmaceuticals and innovative healthcare solutions, position it favorably for long-term growth, especially in light of the ongoing transformations in healthcare delivery. Furthermore, McKesson's strategic partnerships and acquisitions amplify its capabilities, enabling it to tackle emerging market trends. With a history of resilience and adaptation, McKesson is well-positioned to navigate challenges in the healthcare sector, making it an attractive proposition for those seeking a reliable investment in a vital industry.

MCK Intrinsic Value
1 054.31 USD
Undervaluation 42%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
3.9%
=
Gross Profit
13B
/
Revenue
330.2B
What is the Gross Margin of Mckesson Corp?

Based on Mckesson Corp's most recent financial statements, the company has Gross Margin of 3.9%.